Program and presentations
Note: all presentations are available for download in pdf format.
Session 1 (13:00–14:50)
- V. Válek, Minister of Health of the Czech Republic: Welcome (10 min)
- M. Babjuk: Why we need organised early detection of prostate cancer? (10 min)
- L. Dušek: The Czech National Cancer Program: preparedness for organised prostate cancer screening (10 min)
- M. Roobol: What is the evidence about prostate cancer screening? (20 min)
- H. Van Poppel: Risk-stratified early detection for prostate cancer – the EAU approach (20 min)
- O. Bratt: Implementing regional population-based organised prostate cancer testing programmes in Sweden (20 min)
- Discussion (20 min)
Coffee break (14:50–15:20)
Session 2 (15:20–16:30)
- O. Májek: Czech national data on prostate cancer in view of potential effect of organised screening (20 min)
- R. Zachoval: How to implement individualised prostate cancer early detection in Czechia? (20 min)
- J. Ferda: The role of a radiologist in prostate cancer diagnosis and early detection (20 min)
- Discussion (10 min)
Coffee break (16:30-16:50)
Panel discussion (16:50–17:50)
Moderated by M. Babjuk, O. Májek
Biosketches of the speakers
Professor Marek Babjuk has been chairman of the Department of Urology of the Second Faculty of Medicine of the Charles University and Hospital Motol since 2009. He was president of the Czech Urological Society in 2011–2019. He is a member of the European Association of Urology (EAU) and has been elected to its board since 2021. His professional interest is focused mainly on the prevention and treatment of urological malignancies, the application of new minimally invasive treatment techniques and radical operations. He has devoted his research career to the topic of bladder cancer. In 2012-2022, he chaired the EAU guidelines panel for the treatment of non-muscle invasive bladder cancer. Since February 2022, he has been Dean of the Second Faculty of Medicine of the Charles University.
Ola Bratt is Professor of Clinical Cancer Epidemiology at the University of Gothenburg and a consultant urological surgeon at the Prostate Cancer Centre at Sahlgrenska University Hospital in Gothenburg, Sweden. He is the chairman of the Swedish National Prostate Cancer Guidelines Group and the National Working Group for Organised Prostate Cancer Testing (OPT), which since its creation in 2019 coordinates population-based regional projects that are creating an infrastructure in preparation for a future national screening programme.
Ladislav Dušek is Professor at the Masaryk University and Director of MU‘s Institute of Biostatiscs and Analyses. In 2014 he was also appointed Director of the Institute of Health Information and Statistics of the Czech Republic. His research activities include analysis and assessment of biological and clinical data, application of statistical methods and information technologies in biology and medicine. He is one of the leading authors of the Czech national online system for the visualisation of data on cancer epidemiology. Dr Dušek is board member of the Czech Society for Oncology, and Head of its Section for Cancer Epidemiology and Health Informatics
Professor Jiří Ferda has been the Head of the Clinic of Imaging Methods at the Faculty of Medicine of Charles University in Pilsen and the University Hospital Pilsen and the Head of the Anatomical Institute of the Faculty of Medicine of Charles University in Pilsen since 2020. In 2018-2022, he was the Chairman of the Committee of the Czech Radiological Society of the ČLS JEP, now he is its Vice-Chairman. He is a member of the European Society of Radiology (ESR) and the Radiological Society of North America (RSNA). His professional interest is mainly in the field of advanced imaging in cardiovascular and cancer diseases, use of modern molecular and hybrid methods including PET/CT and PET/MRI. His scientific and publishing career is mainly devoted to kidney, prostate and brain tumours and the use of modern radiopharmaceuticals in the detection of tumour and inflammatory processes.
Ondřej Májek is Head of Department of International Affairs at the Institute of Health Information and Statistics of the Czech Republic and the scientific lead of its National Screening Centre, where he is involved in monitoring and evaluation of screening programmes and introduction of new disease early detection projects. He is also an assistant professor and the head analyst of cancer screening programmes at the Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University in Brno, Czech Republic. His research interests include monitoring and evaluation of disease detection programmes, cancer epidemiology, and medical biostatistics. He is a co-author of over 40 articles in international peer-reviewed journals.
Monique Roobol, epidemiologist, is Professor Decision Making in Urology and the Head of the scientific research office within the Department of Urology at Erasmus Medical Centre Rotterdam, The Netherlands since 1991. She is the PI of the European Randomized study of Screening for Prostate Cancer ERSPC, she co-developed the “Rotterdam Prostate Cancer Risk calculator”, and is co-PI of global studies on active surveillance PRIAS and GAP3. Since 2018 she is part of the PIONEER European network for big data in prostate cancer and co-academic lead of another big data project for prostate, breast and lung cancer OPTIMA and co-lead in the upcoming project on awareness and initiatives in prostate cancer screening in the EU (PRAISE-U). She is board member of the ERSPC Foundation, and the chairwoman of the Dutch Prostate Cancer Research Foundation (SWOP), (co)-authored over 425 scientific publications, book chapters and reviews. Her motto is: translate research into useful tools for use within clinical practice: ”Bridging the gap between epidemiology and urology”.
Hendrik Van Poppel
Professor Dr. Hendrik Van Poppel is the Chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit (KU) Leuven. He graduated in General Surgery in 1980, in Urology in 1983 and joined the Academic Unit at KU Leuven after his postgraduate training in London, Barcelona, Copenhagen, Mainz and Rotterdam. He obtained a PhD in Medical Sciences in 1988, became a Fellow of the European Board of Urology in 1992, and a full Professor of Urology in 1993. Professor Van Poppel is a Board Member of the European Association of Urology (EAU), Chairman of the Educational Office of the EAU and Director of the European School of Urology. He is also a member of the American Association of Genito-Urinary Surgeons, Chairman of the Scientific Committee of Europa Uomo, and Faculty Member of the European Society of Medical Oncology. In addition to that, he is a member of the most prominent urological societies worldwide. Professor Van Poppel has published more than 250 papers as first author and has co-authored more than 270 additional publications on urologic oncology. He is a reviewer for all major urological journals.
Professor Vlastimil Válek graduated at the Faculty of Medicine of Masaryk University, with an attestation in the field of radiodiagnostics. In 1985 he started working as a doctor at the University Hospital Brno, where he is currently leading the Department of Radiology and Nuclear Medicine. His focus is on the diagnosis and treatment of tumours, himself a pioneer of certain methods. He publishes in important Czech and international medical journals and regularly lectures at prestigious congresses and universities abroad. He was elected chairman of the Czech Radiological Society of the Czech Medical Society of J. E. Purkyně for the period 2014 to 2017. Since 1993 he has also worked at the Faculty of Medicine of Masaryk University, where he carries out research and teaches future doctors. He holds the position of professor of radiology. At the same time, he is a member of several national and international professional organisations. He has been Minister of Health since December 2021.
Professor Roman Zachoval has been the head of the Urology Clinic of the Thomayer University Hospital and the 3rd Medical Faculty of Charles University in Prague since 1996. He specializes in oncology, especially prostate cancer, neurourology and functional urology. Since 2019 he has been the chairman of the committee of the Czech Urological Society of the Czech Medical Society of Jan Evangelista Purkyně, previously he served as the secretary of its committee for 8 years. His main tasks within the society's activities include collaboration on the National Cancer Plan, the creation of cancer centres and the implementation of a prostate cancer screening programme.